指南与共识类风湿关节炎

泛美风湿病学会联盟类风湿关节炎管理建议

Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis.
指南 / 共识 · Lancet Rheumatol · 2025-11-12

The Pan American League of Associations for Rheumatology has developed evidence-based recommendations for the pharmacological management of rheumatoid arthritis in Latin America.…

要点

  • 早期启动传统合成DMARD,尤其是甲氨蝶呤。
  • 甲氨蝶呤不耐受时可改用肠外甲氨蝶呤。
  • 生物或靶向合成DMARD治疗失败后应更换作用机制。

核心结论

  • 该建议为拉丁美洲临床医生提供实用、循证且结合区域背景的框架,以应对当地独特挑战。

研究设计与样本

  • 由阿根廷、巴西、智利、哥伦比亚、哥斯达黎加、厄瓜多尔、墨西哥、巴拿马、秘鲁、乌拉圭和委内瑞拉的类风湿关节炎专家组成专家组。
  • 以PICO格式提出临床相关问题,并按GRADE方法进行系统文献评价。
  • 建议基于证据质量和专家共识制定,需至少70%投票成员同意方可纳入指南。

主要发现

  • 关键主题包括早期启动传统合成DMARD(尤其是甲氨蝶呤)、甲氨蝶呤不耐受时使用肠外甲氨蝶呤、谨慎使用糖皮质激素、生物或靶向合成DMARD治疗失败后更换作用机制、缓解期减量,以及RA相关间质性肺病和血管炎的指导。
  • 特别关注拉丁美洲社会经济特征下的成本效益和可及性。

关键数值与推荐

  • 建议需至少70%投票成员同意方可纳入指南。

临床怎么用

  • 支持拉丁美洲临床医生在区域背景下管理类风湿关节炎的药物治疗。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Pan American League of Associations for Rheumatology has developed evidence-based recommendations for the pharmacological management of rheumatoid arthritis in Latin America. A panel of rheumatoid arthritis experts from Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Mexico, Panama, Peru, Uruguay, and Venezuela formulated clinically relevant questions in the population, intervention, comparator, outcome format. Systematic literature reviews were done following the Grading of Recommendations Assessment, Development and Evaluation method. Recommendations were formulated based on evidence quality and expert consensus, which required at least 70% agreement among the voting members to be included in the guidelines. Ten recommendations and a treatment algorithm were developed. Key topics include early initiation of conventional synthetic disease-modifying antirheumatic drugs (DMARDs), particularly methotrexate, parenteral methotrexate for intolerance, cautious glucocorticoid use, switching mechanisms of action after unsuccessful biological or targeted synthetic DMARD treatment, tapering in remission, and guidance for rheumatoid arthritis-associated interstitial lung disease and vasculitis. Special attention is given to cost-effectiveness and accessibility considering the socioeconomic characteristics of Latin America. These recommendations aim to support clinicians in Latin America by providing a practical, evidence-based, and contextually relevant framework that addresses the unique challenges faced in the region.

来源:Lancet Rheumatol,查看原文。版权归原作者所有。

引用

  1. Santos Moreno P, García Salinas R, Caballero Uribe CV, et al. Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis. Lancet Rheumatol. 2025. PMID: 41240967. doi:10.1016/S2665-9913(25)00259-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。